Supplement to Exploring metabolic effects of the long-acting growth-differentiation factor 15 (GDF15) receptor agonist (MBL949) in randomized placebo-controlled trials in healthy persons with and without obesity

Supplement to: A Growth Differentiation Factor 15 Receptor Antagonist in Randomized Placebo-Controlled Trials in Healthy or Obese Persons

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-08-20
DOI
https://doi.org/10.5281/zenodo.12637590
Primary Topic
GDF15 and Related Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supplement to Exploring metabolic effects of the long-acting growth-differentiation factor 15 (GDF15) receptor agonist (MBL949) in randomized placebo-controlled trials in healthy persons with and without obesity

Zenodo (CERN European Organization for Nuclear Research)
GDF15 and Related Biomarkers
article

Supplement to Exploring metabolic effects of the long-acting growth-differentiation factor 15 (GDF15) receptor agonist (MBL949) in randomized placebo-controlled trials in healthy persons with and without obesity

article en

Abstract

Supplement to: A Growth Differentiation Factor 15 Receptor Antagonist in Randomized Placebo-Controlled Trials in Healthy or Obese Persons

Zenodo (CERN European Organization for Nuclear Research)
Novartis (China) (CN)
Openalex Percentile: Top 53%
GDF15 and Related Biomarkers
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Supplement to Exploring metabolic effects of the long-acting growth-differentiation factor 15 (GDF15) receptor agonist (MBL949) in randomized placebo-controlled trials in healthy persons with and without obesity · Zenodo (CERN European Organization for Nuclear Research) (2024) | TGRS Research Map | TGRS